News for AstraZeneca Pharma India Limited (ASTRAZEN.NS)

AstraZeneca Pharma India Ltd., on Monday announced that it has received approval from drug regulator Central Drugs Standard Control Organisation to import and distribute cancer treatment medicine Durvalumab solutions in the country.

India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, reflecting a rise in cancer cases. Enhertu, exempted from customs duty, has significantly contributed to AstraZeneca's sales, highlighting the growing demand for innovative cancer treatments.

AstraZeneca Pharma India Ltd. on Monday said that the company received a warning letter from National Stock Exchange of India on Feb. 7. "It was observed that the company is in non-compliance with the provisions of Regulation 18(2)(b) of LODR, as only one independent director attended the audit committee meeting held on May 27, 2024," stated the letter, which was attached by the company in an exchange filing.

Buzzing stocks, stocks to watch: Indian Bank, TVS Motor, Bajaj Healthcare, Ravindra Energy, BPCL, AIA Engineering, IREDA, AstraZeneca, MobiKwik, HFCL, PFC, PowerGrid, Mastek, Satin Creditcare, IRCTC

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).

AstraZeneca Pharma share price: The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL sol from CDSO.

Buzzing stocks Stocks likely to see action today September 24, 2024 Brightcom, Coal India, Firstsource, PNB, PowerGrid, RPower, Reliance Home Finance, Tata Power, AstraZeneca Pharmaceuticals, Samvardhana Motherson, BGR Energy, V2 Retail

AstraZeneca Pharma India to launch Palivizumab in India, a drug to prevent RSV in high-risk children. Stocks rise.

This is part of the government’s broader effort to improve healthcare accessibility and support patients in need, according to government officials

Stocks to watch today, August 13, 2024: GIFT Nifty indicates an indecisive start for the benchmark equity indices on Tuesday. Here is the list of buzzing stocks to watch during today's trading session

AstraZeneca Pharma India Ltd. on Thursday reported a net loss for the first quarter of this financial year.

Stocks to watch: Check out the companies making headlines before the opening bell today, on March 12, 2024.

Trends in the GIFT Nifty indicate a positive start for the broader index in India, with a gain of 26 points or 0.10 percent.

The 30-share BSE Sensex pack was up 287 points or 0.40 per cent to trade at 71,624, while the broader NSE Nifty moved 88 points or 0.41 per cent up to trade at 21,529.

HUL announces key changes to MC, deepening focus on Beauty & Personal Care. Harman Dhillon & Kartik Chandrasekhar join MC as Exec. Directors. Tata Power wins bid to acquire Bikaner-III Neemrana-II Transmission Ltd. Granules India receives US FDA approval for Sildenafil for Oral Suspension. Alkem Labs receives Form 483 with 3 observations. Tata Consumer Products appoints Ashish Goenka as Group CFO. Avantel Ltd receives Provisional Purchase Order worth Rs.67.92 cr. AstraZeneca Pharma India gets permission to import new drug. Lemon Tree Hotels opens Lemon Tree Hotel, Dapoli. Prime Securities Ltd to acquire 60% stake in Prime Global Asset Mgmt. Sadhna Nitro Chem to raise funds via rights issue. Harsha Engineers & Goldi Solar to jointly bid for tender. Mahindra EPC Irrigation wins contract. RSWM Ltd to acquire Spinning, Knitting & Processing Undertaking. Omaxe acquires 75% stake in FBD Real Grow. KPI Green Energy receives orders for solar power projects. Stelis Biopharma & Syngene execute final agreements. LG Balakrishnan to acquire Pondicherry Plant. HFCL & HTL receive orders for Optical Fiber Cables. Salasar Techno Engineering bags EPC contract. GPT Infraprojects receives arbitration amounts. GMM Pfaudler US completes acquisition of Professional Mixing Equip. Bright Outdoor Media clinches Western Railways contract. EP Biocomposites gets order for STP. Shelter Pharma secures order from Taha Drugs & Chemicals. Trishakti Industries obtains contract from PSU in oil & gas.

Sensex, Nifty updates on 03 October 2023 – Indian shares closed lower on Tuesday, dragged by auto stocks on mixed sales data in September, while concerns over elevated interest rates also weighed on sentiment. The NSE Nifty 50 index settled 0.56 per cent down at 19,528.75, while the S&P BSE Sensex fell 0.48 per cent to 65,512.10. Auto stocks fell 1.20 per cent, dragged by Eicher Motors shedding 2.68 per cent, among the most on the blue-chip Nifty 50, after its September motorcycle sales fell 4 per cent.

ITC Ltd, Vodafone Idea Ltd, Indiabulls Housing Finance, KNR Constructions Ltd, AstraZeneca Pharma India, Wockhardt Ltd and Saksoft Ltd are among a handful of companies that will announce their quarterly results today.

Prashant Jain has invested in a diversified portfolio of promising small and nano-cap stocks from different sectors. Some stocks are favourite of luminaries like Dolly Khanna, Ashish Kacholia, Anil…

The Nifty 50 index and the S&P BSE Sensex closed slightly lower on Thursday.